Head-to-head · Cost-Efficiency Index
Human+ vs Sumbare Wellness
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Human+
Cost-first shoppers who want pharmacy-wholesale pricing via a flat membership, in any state.
Visit Human+Sumbare Wellness
Shoppers comfortable with a floor price that's only confirmed after a clinical review, rather than a locked-in rate.
Visit Sumbare WellnessThe verdict
Human+ and Sumbare Wellness tie on the Cost-Efficiency Index at 58/100, so neither wins outright on the numbers. For most shoppers we'd start with Human+ (ranked #287, a hair above #292) — Cost-first shoppers who want pharmacy-wholesale pricing via a flat membership, in any state. But Sumbare Wellness is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Human+.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Human+ | Sumbare Wellness |
|---|---|---|
| Cost-Efficiency Index | 58/100 | 58/100 |
| Semaglutide / mo | Not disclosed | $199/mo (compounded) |
| Tirzepatide / mo | Not disclosed | $199/mo (compounded) |
| Semaglutide / yr (modeled) | — | $2,388 |
| Tirzepatide / yr (modeled) | — | $2,388 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #287 | #292 |
Human+
58/100Where the value is
- Cost-transparent model: a flat monthly membership with prescriptions billed at pharmacy-wholesale cost instead of marked up
- Available via telehealth in all 50 states
- Filled by US 503A compounding pharmacies and reviewed by board-certified US-licensed clinicians
The tradeoffs
- Specific GLP-1 medications and pricing are not published — you only see them after starting the intake
- Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
Sumbare Wellness
58/100Where the value is
- Offers both semaglutide and tirzepatide plus a microdose program
- States clinical outcome averages (15% vs 20% body weight loss) on the pricing-adjacent page
- Claims 'no hidden fees' with pricing confirmed transparently after clinical review
The tradeoffs
- '$199/mo' is a floor, not a locked price -- actual cost is only confirmed after provider review
- No medical director or specific pharmacy partner named
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.